|
Faegre Drinker Biddle & Reath LLP 2200 Wells Fargo Center 90 South Seventh Street Minneapolis, Minnesota 55402 +1 612 766 7000 main +1 612 766 1600 fax |
May 14, 2025
EIDP, Inc.
974 Centre Road
Wilmington, DE 19805
Ladies and Gentlemen:
We have acted as counsel for EIDP, Inc. (formerly known as E. I. du Pont de Nemours and Company), a Delaware corporation (the “Company”), in connection with the purchase by the several underwriters (the “Underwriters”) listed in Schedule B to the Terms Agreement dated May 12, 2025 (the “Terms Agreement”), among the Company and BNP Paribas Securities Corp., Citigroup Global Markets Inc. and HSBC Securities (USA) Inc. as representatives (the “Representatives”) of the Underwriters, of $500,000,000 aggregate principal amount of 5.125% Notes due 2032 (the “Notes”) issued under an Indenture dated as of May 15, 2020 (the “Original Indenture”) between the Company and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association) (the “Trustee”), as supplemented by the Third Supplemental Indenture dated as of May 14, 2025 (the “Third Supplemental Indenture”) between the Company and the Trustee (the Original Indenture, as supplemented by the Third Supplemental Indenture, being herein called the “Indenture”).
This opinion letter is being delivered in accordance with the requirements of Item 601(b)(5)(i) of Regulation S-K.
In rendering the opinions expressed herein, we have examined:
(i) the Registration Statement on Form S‑3ASR (Registration Nos. 333-287099 and 333-287099-01) (the “Registration Statement”) filed by Corteva, Inc. and the Company with the Securities and Exchange Commission (the “Commission”) on May 8, 2025, including the exhibits thereto and the base prospectus constituting a part thereof, including the documents incorporated by reference therein, relating to the offering from time to time of the securities referred to therein pursuant to Rule 415 promulgated under the Securities Act of 1933, as amended (the “Act”);
(ii) the preliminary prospectus supplement dated May 12, 2025 and the final prospectus supplement dated May 12, 2025 (the “Prospectus Supplement”), including the documents incorporated by reference therein, filed with the Commission pursuant to Rule 424 promulgated under the Act;
(iii) the Underwriting Agreement dated May 12, 2025 (the “Underwriting Agreement”), by and among the Company and the Representatives of the Underwriters;
(iv) the Terms Agreement;
